- Home
- NSTS vs BDSX Comparison
NSTS vs BDSX Comparison
Compare NSTS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- BDSX
- Stock Information
- Founded
- NSTS 1921
- BDSX 2005
- Country
- NSTS United States
- BDSX United States
- Employees
- NSTS N/A
- BDSX N/A
- Industry
- NSTS Savings Institutions
- BDSX Precision Instruments
- Sector
- NSTS Finance
- BDSX Health Care
- Exchange
- NSTS Nasdaq
- BDSX Nasdaq
- Market Cap
- NSTS 63.0M
- BDSX 61.9M
- IPO Year
- NSTS N/A
- BDSX 2020
- Fundamental
- Price
- NSTS $11.34
- BDSX $7.36
- Analyst Decision
- NSTS
- BDSX Strong Buy
- Analyst Count
- NSTS 0
- BDSX 5
- Target Price
- NSTS N/A
- BDSX $32.50
- AVG Volume (30 Days)
- NSTS 5.5K
- BDSX 122.1K
- Earning Date
- NSTS 11-12-2025
- BDSX 10-31-2025
- Dividend Yield
- NSTS N/A
- BDSX N/A
- EPS Growth
- NSTS N/A
- BDSX N/A
- EPS
- NSTS N/A
- BDSX N/A
- Revenue
- NSTS $9,435,000.00
- BDSX $76,556,000.00
- Revenue This Year
- NSTS N/A
- BDSX $18.80
- Revenue Next Year
- NSTS N/A
- BDSX $27.76
- P/E Ratio
- NSTS N/A
- BDSX N/A
- Revenue Growth
- NSTS 69.39
- BDSX 25.70
- 52 Week Low
- NSTS $10.13
- BDSX $3.44
- 52 Week High
- NSTS $13.32
- BDSX $34.40
- Technical
- Relative Strength Index (RSI)
- NSTS 32.54
- BDSX 68.31
- Support Level
- NSTS $11.31
- BDSX $7.36
- Resistance Level
- NSTS $11.65
- BDSX $7.95
- Average True Range (ATR)
- NSTS 0.18
- BDSX 0.58
- MACD
- NSTS -0.03
- BDSX -0.16
- Stochastic Oscillator
- NSTS 3.62
- BDSX 48.31
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.